• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经治疗的β地中海贫血中的扁平椎

Platyspondyly in treated beta-thalassemia.

作者信息

Orzincolo C, Castaldi G, Scutellari P N

机构信息

Department of Radiology, St. Anna Hospital, Ferrara, Italy.

出版信息

Eur J Radiol. 1994 May;18(2):129-33. doi: 10.1016/0720-048x(94)90280-1.

DOI:10.1016/0720-048x(94)90280-1
PMID:8055985
Abstract

Flattening of the vertebral bodies with a platyspondyly appearance is described in 14 patients selected for evaluation of short stature from 106 patients affected by thalassemia major, who received an intensive transfusion regimen combined with continuous chelation therapy. The vertebral body height/width ratio was decreased at the level of all the investigated tracts, namely, cervical and/or dorsal and/or lumbar. The flattening of the vertebral bodies may be due to suppression of intramedullary hematopoiesis by a high transfusion regimen. The reduced intravertebral pressure due to disturbed hemopoiesis could cause weight-bearing and other biological stresses to provoke a reduction in vertebral body height.

摘要

在106例重型地中海贫血患者中,选取14例因身材矮小接受评估的患者,这些患者接受强化输血方案并联合持续螯合治疗。在所有研究节段,即颈椎和/或胸椎和/或腰椎水平,椎体高度/宽度比均降低。椎体扁平可能是由于高输血方案抑制了骨髓造血。造血紊乱导致椎体内压力降低,可能使负重及其他生物应力促使椎体高度降低。

相似文献

1
Platyspondyly in treated beta-thalassemia.经治疗的β地中海贫血中的扁平椎
Eur J Radiol. 1994 May;18(2):129-33. doi: 10.1016/0720-048x(94)90280-1.
2
[Platyspondylisis+ in beta-thalassemia major].[重型β地中海贫血中的扁平椎病(加重)]
Radiol Med. 1992 Dec;84(6):731-5.
3
Deferoxamine-induced platyspondyly in hypertransfused thalassemic patients.
Pediatr Radiol. 1995 Nov;25 Suppl 1:S122-4.
4
Long-term follow-up of skeletal dysplasia in thalassaemia major.
J Pediatr Endocrinol Metab. 1998;11 Suppl 3:817-25.
5
Spinal deformities in deferoxamine-treated homozygous beta-thalassemia major patients.去铁胺治疗的重型纯合子β地中海贫血患者的脊柱畸形
Pediatr Radiol. 1993;23(7):525-8. doi: 10.1007/BF02012139.
6
[The evolutionary effects of therapy on the skeletal lesions in beta-thalassemia].
Radiol Med. 1994 Apr;87(4):381-8.
7
Deferoxamine-induced bone dysplasia in patients with thalassemia major.去铁胺诱发的重型地中海贫血患者骨发育异常
AJR Am J Roentgenol. 1991 Mar;156(3):561-5. doi: 10.2214/ajr.156.3.1899759.
8
Improving survival with deferiprone treatment in patients with thalassemia major: a prospective multicenter randomised clinical trial under the auspices of the Italian Society for Thalassemia and Hemoglobinopathies.去铁酮治疗改善重型地中海贫血患者生存率:一项在意大利地中海贫血和血红蛋白病协会支持下开展的前瞻性多中心随机临床试验。
Blood Cells Mol Dis. 2009 May-Jun;42(3):247-51. doi: 10.1016/j.bcmd.2009.01.002. Epub 2009 Feb 23.
9
Outcome of thalassemia treated with conventional therapy.采用传统疗法治疗地中海贫血的结果。
Bone Marrow Transplant. 1993;12 Suppl 1:2-4.
10
[Measurement of the secretion of growth hormone in patients with thalassemia major].[重型地中海贫血患者生长激素分泌的测定]
Minerva Endocrinol. 1993 Sep;18(3 Suppl 1):62-5.